Vical vax demonstrates cross-reactivity against California,Texas and Mexico H1N1 strains Vical Pandemic Influenza Vaccine Demonstrates Cross-reactivity Against California, Texas and Mexico H1N1 Strains Vical Incorporated (Nasdaq:VICL) announced today that the company's DNA … [Read more...] about Vical Pandemic Influenza Vaccine Shows Strong Results in H1N1 Study
Swine Flu Fears Spur Over 3,000 Volunteers Fears about swine flu have spurred more than 3,000 people so far to volunteer to take part in upcoming clinical trials of a new vaccine. That's already more than the number scientists will need at eight different sites around the … [Read more...] about H1N1 Trial Researchers Fielding Calls From Thousands of Volunteers
Big Pharma stockholders think so San Diego-based Vical, a firm who is developing an H1N1 vaccine under an agreement with the U.S. Navy saw company shares climb 45 cents, to $2.65 on positive clinical trial news this week. Vical researches and develops biopharmaceutical … [Read more...] about Is There an Upside to the Swine Flu Pandemic?